Helen Susan Kim Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Helen Susan Kim.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Helen Susan Kim for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 53.90 | 2,400 | 129,360 | 161,301 | |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 53.90 | 16,299 | 878,516 | 163,701 | |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 51.43 | 31,601 | 1,625,239 | 52,499 | |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 79.92 | 400 | 31,968 | 18,664 | 19.1 K to 18.7 K (-2.10 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 79.26 | 600 | 47,556 | 19,064 | 19.7 K to 19.1 K (-3.05 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 76.93 | 200 | 15,386 | 19,664 | 19.9 K to 19.7 K (-1.01 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 75.52 | 200 | 15,104 | 19,864 | 20.1 K to 19.9 K (-1.00 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 73.64 | 100 | 7,364 | 20,064 | 20.2 K to 20.1 K (-0.50 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 72.69 | 200 | 14,538 | 20,164 | 20.4 K to 20.2 K (-0.98 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 71.23 | 200 | 14,246 | 20,364 | 20.6 K to 20.4 K (-0.97 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 70.29 | 300 | 21,087 | 20,564 | 20.9 K to 20.6 K (-1.44 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 68.95 | 200 | 13,790 | 20,864 | 21.1 K to 20.9 K (-0.95 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 53.90 | 2,400 | 129,360 | 21,064 | 18.7 K to 21.1 K (+12.86 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 72.60 | 300 | 21,780 | 18,664 | 19 K to 18.7 K (-1.58 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 71.65 | 1,800 | 128,970 | 18,964 | 20.8 K to 19 K (-8.67 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 71.16 | 9,049 | 643,927 | 20,764 | 29.8 K to 20.8 K (-30.35 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 69.63 | 2,553 | 177,765 | 29,813 | 32.4 K to 29.8 K (-7.89 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 68.74 | 900 | 61,866 | 32,366 | 33.3 K to 32.4 K (-2.71 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 67.49 | 2,500 | 168,725 | 33,266 | 35.8 K to 33.3 K (-6.99 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 66.32 | 10,326 | 684,820 | 35,766 | 46.1 K to 35.8 K (-22.40 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 65.81 | 18,072 | 1,189,318 | 46,092 | 64.2 K to 46.1 K (-28.17 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 63.00 | 2,400 | 151,200 | 64,164 | 66.6 K to 64.2 K (-3.61 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 53.90 | 16,299 | 878,516 | 66,564 | 50.3 K to 66.6 K (+32.43 %) |
| Mar 02 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 51.43 | 31,601 | 1,625,239 | 50,265 | 18.7 K to 50.3 K (+169.32 %) |